DECISION OF THE EEA JOINT COMMITTEE No 60/2020

of 30 April 2020

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/485]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2019/1942 of 22 November 2019 not approving carbendazim as an existing active substance for use in biocidal products of product-type 9 ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 ( 7 ) is to be incorporated into the EEA Agreement.

(8) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzc (Commission Implementing Regulation (EU) 2019/1692) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzd.

32019 D 1942 : Commission Implementing Decision (EU) 2019/1942 of 22 November 2019 not approving carbendazim as an existing active substance for use in biocidal products of product-type 9 ( OJ L 303, 25.11.2019, p. 29 ).

12zzzzzze.

32019 D 1950 : Commission Implementing Decision (EU) 2019/1950 of 25 November 2019 postponing the expiry date of approval of K-HDO for use in biocidal products of product-type 8 ( OJ L 304, 26.11.2019, p. 19 ).

12zzzzzzf.

32019 D 1951 : Commission Implementing Decision (EU) 2019/1951 of 25 November 2019 postponing the expiry date of approval of tebuconazole for use in biocidal products of product-type 8 ( OJ L 304, 26.11.2019, p. 21 ).

12zzzzzzg.

32019 D 1959 : Commission Implementing Decision (EU) 2019/1959 of 26 November 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products of product-types 2 and 7 ( OJ L 306, 27.11.2019, p. 40 ).

12zzzzzzh.

32019 D 1960 : Commission Implementing Decision (EU) 2019/1960 of 26 November 2019 not approving silver zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 ( OJ L 306, 27.11.2019, p. 42 ).

12zzzzzzi.

32019 D 1969 : Commission Implementing Decision (EU) 2019/1969 of 26 November 2019 postponing the expiry date of approval of IPBC for use in biocidal products of product-type 8 ( OJ L 307, 28.11.2019, p. 45 ).

12zzzzzzj.

32019 D 1973 : Commission Implementing Decision (EU) 2019/1973 of 27 November 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products of product-types 2 and 7 ( OJ L 307, 28.11.2019, p. 58 ).’

Article 2

The texts of Implementing Decisions (EU) 2019/1942, (EU) 2019/1950, (EU) 2019/1951, (EU) 2019/1959, (EU) 2019/1960, (EU) 2019/1969 and (EU) 2019/1973 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 1 May 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( * ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 30 April 2020.

For the EEA Joint Committee

The President

Clara GANSLANDT

( 1 ) OJ L 303, 25.11.2019, p. 29 .

( 2 ) OJ L 304, 26.11.2019, p. 19 .

( 3 ) OJ L 304, 26.11.2019, p. 21 .

( 4 ) OJ L 306, 27.11.2019, p. 40 .

( 5 ) OJ L 306, 27.11.2019, p. 42 .

( 6 ) OJ L 307, 28.11.2019, p. 45 .

( 7 ) OJ L 307, 28.11.2019, p. 58 .

( * ) No constitutional requirements indicated.